{
    "nct_id": "NCT06108206",
    "official_title": "Adaptive Radiotherapy Based on Multi-Parametric Diffusion- and Perfusion-weighted Magnetic Resonance Imaging in Patients With Newly Diagnosed High-Grade Glioma",
    "inclusion_criteria": "* Histopathologically proven diagnosis of glioblastoma, anaplastic astrocytoma, or anaplastic oligodendroglioma\n* History and physical examination within 28 days prior to enrollment\n* Karnofsky performance status 70 or greater\n* Age 18 years or greater\n* Negative pregnancy test for females of childbearing potential before 1st research MRI, performed in accordance to institutional guidelines.\n* Plan to receive 59.4-60 Gy in 30-33 fractions of radiotherapy. Glioblastoma patients over 65 year-old can receive hypofractionated radiotherapy including 40 Gy in 15 fractions.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Prior therapy for tumor except for biopsy or resection, including prior radiotherapy to the brain.\n* Clinical or radiological evidence of metastatic disease outside the brain\n* Prior malignancy (except non-melanomatous skin cancer) unless disease free for a minimum of 2 years",
    "miscellaneous_criteria": ""
}